https://t.co/nvnPE2JP8w?amp=1
Ms Halasz said the rapid testing capacity would also relieve the “acute shortage of testing in Australia”.She said a lack of the PCR (Polymerase Chain Reaction) equipment needed for the COVID-19 mouth and nose swabs had so far strictly limited the level of testing in Australia, even though as of Saturday the country had tested 190,000 people which, on a per capita basis, was higher than most.China first started using the pin prick tests on February 24 and since March 5 the tests had been rolled out in the UK, Belgium, Spain and Germany.She said Cellmid would not have been able to access the test kits without its long standing relationship with Chinese research and pharmaceutical communities.Australia’s therapeutic goods regulator, the TGA, had also acted with “breathtaking” speed, approving the pin prick tests on March 25, just two days after Cellmid submitted its application.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-211
-
-
- There are more pages in this discussion • 1,060 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable